Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don't work well in rheumatoid ...

Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

Scientists are making progress in understanding and treating these disorders, which can go unrecognized for years.

Cold hands and feet can easily be dismissed as a standard result of winter temperatures, but in some cases it could actually ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and strokes at unusually young ages. Kaplan’s research suggests those aptly named ...

SBT-77-7101 shows favourable safety and early signs of efficacy in patients with refractory RA Sonoma Biotherapeutics has announced positive interim results from its ongoing phase 1 Regulate-RA trial ...

Anti-citrullinated protein antibodies (ACPA) are a key biomarker in rheumatoid arthritis (RA), but a recent study has suggested that ACPA studies may not fully identify the biological distinctions ...

Please provide your email address to receive an email when new articles are posted on . Inflammatory arthritis arising from immune checkpoint therapy is immunologically distinct from conventional ...

With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the treatment of rheumatoid arthritis. London-based Elevara was founded by ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

Pollution caused by fire smoke has been linked to higher risk of rheumatoid arthritis-interstitial lung disease (RA-ILD). The study, which appears in Arthritis & Rheumatology, measured levels of ...